News About: Pharm. Industry
Pharmaceutical industry output grows 9.1 percent
Drug output grew at a brisk pace last year even amid sluggish domestic consumption and corporate investment as consumers tightened their belts against the global economic slowdown.
According to data released by the...
Leading drug makers to boost cleanup drive
Korea’s 10 leading manufacturers will step up its fight against chronic illegal rebate practices whereby doctors and pharmacists receive money from drug makers in return for prescribing or recommending their products....
Ahngook to release new antitussive drug
Ahngook Pharm plans to launch Anycough capsule (theobromine) from next month.
“Our accumulated data indicate the actions of theobromine appear to be peripherally mediated. We conclude theobromine is a novel and pro...
Fast and accurate detection of swine influenza using Seegene’s Seeplex
Seeegene, Inc., a local biotechnology company specialized in molecular diagnostics and research applications, said on June 12 that the Seoul National University Hospital confirmed additional patients with H1N1 influen...
Discard of asbestos-contaminated talc medicines to stir debate
So far, about 1,100 medication items produced by 120 companies have been recalled and discarded as originally planned, according to the Korea Food and Drug Administration.
Still, the pharmaceutical industry expects...
Mindset change needed to foster domestic pharmaceutical industry
There are growing voices in the industry that Korean pharmaceutical companies should focus more on the distribution sector by maintaining a closer relationship with pharmaceutical wholesalers.
Multinational pharmac...
Samjin raises sales target over 3 medicines
Samjin Pharm has raised its sales target of three drugs, such as antiplatelet agent ‘Platless (clopidogrel)’, antihypertesive ‘ARB’ and anti-dementia drug, in the domestic market for this year as these products will b...
Concerns growing over tougher rebate regulation
There are mounting concerns that newly formulated industry's guidelines for fair trade will limit the marketing scope of domestic pharmaceutical firms.
Health Minister Jeon Jae-hee expressed the government's strong...
Choong-wae to conduct Phase 3 trial over new biological therapy, Actemra
Choong-wae Pharm said on June 17 that the Korea Food and Drug Administration has approved Phase 3 study of Actemra (tocilizumab), to treat patients with rheumatoid arthritis (RA).
The company entered into an exclus...
Handok to introduce transdermal continuous glucose monitoring system
Handok Pharm announced on June 15 that it has signed a license agreement with the US based Echo Therapeutics, Inc., under which Echo granted Handok to market, sell and distribute Echo's Symphony™ tCGM (transdermal Con...
